Scarica l'app Stockscreener
0.5201
9.85%
-0.0568
Aspira Womens Health Inc Borsa (AWH) Ultime notizie
Bioxytran (OTCMKTS:BIXT) to Release Cancer Preprint Revealing Potential Immunotherapy EnhancementOn January 10, 2025, Bioxytran Inc., a clinical-stage biotechnology company focused on developing oral and intravenous drugs for various conditions, a - Defense World
Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com - Defense World
Aspira Women’s Health Appoints Mike Buhle as SVP of Commercial Operations - citybiz
Aspira Women's Health Inc. Appoints Mike Buhle as SVP of Commercial Operations - Marketscreener.com
Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations - AccessWire
Aspira Women's Health CFO resigns, CEO assumes duties - Investing.com
Aspira Women’s Health CFO Resignation and Leadership Update - TipRanks
AWH Stock Surges Over 5% Amid Mixed Analyst Ratings - GuruFocus.com
Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com - Defense World
Aspira Women's Health in Shelton to use $10M grant to create blood test to detect endometriosis - CTPost
Aspira Women’s Health (NASDAQ:AWH) Earns Hold Rating from Analysts at StockNews.com - Defense World
Organon & Co. (NYSE: OGN) Reduces Board Size Following Resignation of Director - Defense World
Aspira Women's Health's SWOT analysis: stock outlook amid diagnostic growth - Investing.com India
Aspira Women's Health CEO steps down, interim appointed By Investing.com - Investing.com Canada
Aspira Women’s Health CEO Transition and Leadership Change - TipRanks
AWHAspira Women's Health Inc. Latest Stock News & Market Updates - StockTitan
Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer - citybiz
Aspira Women’s Health Appoints Dr. Sandra Milligan as Interim CEO - citybiz
Akari Therapeutics Strengthens Leadership: Former CFO Returns After $50M Fundraising Success - StockTitan
Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO - The Manila Times
Aspira Women's Health CEO Steps Down Following OvaWatch Launch, $10M Research Grant Success - StockTitan
StockNews.com Begins Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World
Aspira Women's Health's SWOT analysis: stock faces growth potential amid financial hurdles - Investing.com Nigeria
CURE® SURVEY UNVEILS WHAT INVESTORS LOOK FOR IN FUNDING WOMEN'S HEALTH - PR Newswire
AWS supports ARPA-H Sprint for Women’s Health to advance crucial research and solutions - AWS Blog
Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award - The Manila Times
Aspira Women's Health Secures $2M ARPA-H Grant for AI-Powered Endometriosis Test - StockTitan
StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World
Aspira: Q3 Earnings Snapshot - New Haven Register
Aspira Women's Health Inc. (AWH) reports earnings - Quartzy
Aspira Women's Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Aspira Women’s Health Inc. (NASDAQ:AWH) Q3 2024 Earnings Call Transcript - MSN
Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... - Yahoo Finance
Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... By GuruFocus - Investing.com Canada
Aspira Women’s Health Reports Q3 2024 Growth and Strategic Advances - TipRanks
ARMISTICE CAPITAL, LLC Expands Stake in Aspira Womens Health Inc - GuruFocus.com
Aspira Women’s Health reports Q3 revenue $2.3M, consensus $2.73M - TipRanks
Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results - The Manila Times
Aspira Women's Health Q3: OvaWatch Grows 27%, Secures $10M Federal Contract | AWH Stock News - StockTitan
Aspira Women's Health Inc (AWH) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated by Analysts at StockNews.com - Defense World
Aspira Women?s Health Expands Co-Marketing and Distribution Collaboration with BioReference to Include OvaWatch - Marketscreener.com
Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® - The Manila Times
Aspira Women's Health Expands BioReference Partnership, Reaches 15M+ Women With OvaWatch | AWH Stock News - StockTitan
FDA's LDT RULE: Steps to Prepare for Your FDA 1st Milestone SubmissionDARKDaily.com - DARKDaily.com - Laboratory News
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):